Codes / ICD10CM / T56.814A

T56.814A Toxic effect of thallium, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Thallium, Undetermined, Initial Encounter
  • ICD-10-CM Code: T56.814A

Summary

This condition occurs when exposure to thallium results in harmful effects on the body, with the cause of exposure classified as undetermined. Thallium toxicity can develop through ingestion, inhalation, or skin contact, leading to systemic effects that may involve multiple organ systems. The initial encounter designation indicates this is the patient's first presentation for this condition.

Causes

Exposure to thallium may result from unknown or unconfirmed sources. Potential routes include ingestion of contaminated substances, inhalation of thallium-containing particles, or skin contact with thallium compounds. The exact source of exposure is not documented or cannot be determined at the time of initial evaluation.

Risk Factors

  • Occupational exposure in industries involving thallium, such as electronics manufacturing or chemical processing.
  • Living near industrial sites or waste areas where thallium contamination may occur.
  • Inadequate safety measures when handling thallium-containing products.
  • Consumption of food or water from sources with potential thallium contamination.

Symptoms

  • Gastrointestinal issues like nausea, vomiting, and abdominal pain.
  • Neurological symptoms such as peripheral neuropathy, tremors, or confusion.
  • Hair loss (alopecia) and skin changes.
  • Cardiac or respiratory distress in severe cases.
  • Renal dysfunction or failure.

Diagnosis

Diagnosis involves assessing clinical symptoms and exposure history. Laboratory tests, including thallium levels in blood or urine, help confirm toxicity. Imaging or other tests may evaluate organ system involvement. The undetermined classification indicates the exposure source was not identified during the initial encounter.

Treatment Options

Treatment focuses on removing the source of exposure and managing symptoms. Supportive care may include hydration, monitoring of vital signs, and addressing specific organ system effects. Chelation therapy or other interventions may be considered based on severity and clinical presentation.

Prognosis and Follow-Up

Prognosis depends on the extent of exposure and organ involvement. Early recognition and treatment improve outcomes. Follow-up care may involve monitoring for delayed effects and assessing recovery of affected organ systems. Long-term management may be necessary for persistent symptoms or complications.

Complications

Complications can include permanent neurological damage, renal impairment, or cardiovascular issues. Severe toxicity may lead to multi-organ failure. Hair loss and skin changes may persist, and some effects may be irreversible depending on exposure severity.

Lifestyle & Prevention

Avoiding known sources of thallium exposure reduces risk. Proper handling of thallium-containing materials and adherence to safety protocols in industrial settings are important. Consuming water and food from verified safe sources minimizes environmental exposure risks.

When to Seek Professional Help

Seek immediate medical attention if thallium exposure is suspected or if symptoms such as severe gastrointestinal distress, neurological changes, or respiratory difficulty occur. Early evaluation is critical for effective management and to prevent progression of toxicity.

Tips for Medical Coders

Use T56.814A for the initial encounter of thallium toxicity with an undetermined exposure cause. Document the encounter as initial and confirm the absence of identified exposure source. Ensure clinical documentation supports the undetermined classification and initial encounter status.

Book a walkthrough

T56.814A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.